These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12406801)

  • 1. Hepatitis B vaccination among research participants, Seattle, Washington.
    Hagan H; Thiede H; McGough JP; Alexander ER
    Am J Public Health; 2002 Nov; 92(11):1756. PubMed ID: 12406801
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccine uptake among injecting drug users.
    Lawson J; Holtby I; Eynon C
    J Public Health (Oxf); 2004 Mar; 26(1):116-7. PubMed ID: 15044587
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.
    Lum PJ; Ochoa KC; Hahn JA; Page Shafer K; Evans JL; Moss AR;
    Am J Public Health; 2003 Jun; 93(6):919-23. PubMed ID: 12773355
    [No Abstract]   [Full Text] [Related]  

  • 4. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.
    Des Jarlais DC; Fisher DG; Newman JC; Trubatch BN; Yancovitz M; Paone D; Perlman D
    Am J Public Health; 2001 Nov; 91(11):1791-2. PubMed ID: 11684603
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B vaccination for injection drug users--Pierce County, Washington, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 May; 50(19):388-90, 399. PubMed ID: 11465908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination in prisons.
    Awofeso N
    Bull World Health Organ; 2002; 80(7):569-74. PubMed ID: 12163921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination strategies for targeted and difficult-to-access groups.
    Trubatch BN; Fisher DG; Cagle HH; Fenaughty AM
    Am J Public Health; 2000 Mar; 90(3):447. PubMed ID: 10705870
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of seroconversion after hepatitis B virus immunization.
    Diamond C
    Am J Public Health; 2004 Mar; 94(3):358; author reply 358-9. PubMed ID: 14998792
    [No Abstract]   [Full Text] [Related]  

  • 9. Universal hepatitis B vaccination.
    Kretzschmar M; de Wit A
    Lancet Infect Dis; 2008 Feb; 8(2):85-7; author reply 90. PubMed ID: 18222156
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B vaccination.
    Gray J; Hewett N; Hiley A
    Br J Gen Pract; 2004 Sep; 54(506):704. PubMed ID: 15353063
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination could improve overall health in a high risk population.
    Hagan H
    West J Med; 2000 Jan; 172(1):21. PubMed ID: 10695437
    [No Abstract]   [Full Text] [Related]  

  • 12. JCVI response on hepatitis B vaccination.
    Joint Committee on Vaccination and Immunisation
    Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Offer hepatitis B vaccination to the addicts. Transmission of hepatitis B among intravenous drug abusers].
    Struve J; Käll K; Oksanen A; Stendahl P
    Lakartidningen; 1993 Jun; 90(23):2225-7. PubMed ID: 8502085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denmark scales up hepatitis B screening and vaccination for risk groups.
    Cowan SA
    Euro Surveill; 2005 Nov; 10(11):E051103.4. PubMed ID: 16794275
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential of specialist drug services to deliver hepatitis B vaccination.
    Morrison DS; Gilchrist G; Ahmed S
    Commun Dis Public Health; 2002 Dec; 5(4):321-3. PubMed ID: 12564250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B is an occupational risk for health personnel. Preventive vaccination is recommended].
    Struve J; Aronsson B; Forsgren M; Frenning B; von Sydow M; Weiland O
    Lakartidningen; 1996 Mar; 93(10):884-8. PubMed ID: 8656790
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy and antibody follow-up of hepatitis B vaccine within the South African expanded programme on immunisation.
    Mphahlele MJ; Tshatsinde EA; Burnett RJ; Aspinall S
    S Afr Med J; 2002 Aug; 92(8):612-3. PubMed ID: 12244619
    [No Abstract]   [Full Text] [Related]  

  • 19. The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic.
    Ramasamy P; Lintzeris N; Sutton Y; Taylor H; Day CA; Haber PS
    Addiction; 2010 Feb; 105(2):329-34. PubMed ID: 20078489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managerial considerations in implementing hepatitis B vaccination programs among drug-using cohorts.
    Awofeso N
    Addiction; 2002 Dec; 97(12):1611-3; author reply 1613-4. PubMed ID: 12472648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.